» Articles » PMID: 26557372

The Osteocyte: Key Player in Regulating Bone Turnover

Overview
Journal RMD Open
Specialty Rheumatology
Date 2015 Nov 12
PMID 26557372
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Osteocytes are the most abundant cell type in bone and are distributed throughout the mineralised bone matrix forming an interconnected network that ideally positions them to sense and to respond to local biomechanical and systemic stimuli to regulate bone remodelling and adaptation. The adaptive process is dependent on the coordinated activity of osteoclasts and osteoblasts that form a so called bone multicellular unit that remodels cortical and trabecular bone through a process of osteoclast-mediated bone resorption, followed by a phase of bone formation mediated by osteoblasts. Osteocytes mediate their effects on bone remodelling via both cell-cell interactions with osteoclasts and osteoblasts, but also via signaling through the release of soluble mediators. The remodelling process provides a mechanism for adapting the skeleton to local biomechanical factors and systemic hormonal influences and for replacing bone that has undergone damage from repetitive mechanical loading.

Citing Articles

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.

Chen Y, Xiao H, Liu Z, Teng F, Yang A, Geng B Biomolecules. 2024; 14(8).

PMID: 39199358 PMC: 11352324. DOI: 10.3390/biom14080970.


Daratumumab Treatment for "Truly Frail" Elderly Myeloma Patients.

Horigome Y, Suzuki K, Suzuki T Life (Basel). 2024; 14(3).

PMID: 38541713 PMC: 10971975. DOI: 10.3390/life14030389.


YAP/TAZ as Molecular Targets in Skeletal Muscle Atrophy and Osteoporosis.

Kwon Y Aging Dis. 2024; .

PMID: 38502585 PMC: 11745433. DOI: 10.14336/AD.2024.0306.


Pip5k1c expression in osteocytes regulates bone remodeling in mice.

Lin S, Tao C, Yan Q, Gao H, Qin L, Zhong Y J Orthop Translat. 2024; 45:36-47.

PMID: 38495744 PMC: 10943313. DOI: 10.1016/j.jot.2023.10.008.


Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies.

Di Paola A, Marrapodi M, Di Martino M, Giliberti G, Di Feo G, Rana D Int J Mol Sci. 2024; 25(5).

PMID: 38474150 PMC: 10932404. DOI: 10.3390/ijms25052902.


References
1.
Chan B, Fuller E, Russell A, Smith S, Smith M, Jackson M . Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage. 2011; 19(7):874-85. DOI: 10.1016/j.joca.2011.04.014. View

2.
Bellido T, Saini V, Divieti Pajevic P . Effects of PTH on osteocyte function. Bone. 2012; 54(2):250-7. PMC: 3552098. DOI: 10.1016/j.bone.2012.09.016. View

3.
Rhee Y, Allen M, Condon K, Lezcano V, Ronda A, Galli C . PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. J Bone Miner Res. 2010; 26(5):1035-46. PMC: 3179307. DOI: 10.1002/jbmr.304. View

4.
Ben-awadh A, Delgado-Calle J, Tu X, Kuhlenschmidt K, Allen M, Plotkin L . Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes. Endocrinology. 2014; 155(8):2797-809. PMC: 4098003. DOI: 10.1210/en.2014-1046. View

5.
Morse A, McDonald M, Kelly N, Melville K, Schindeler A, Kramer I . Mechanical load increases in bone formation via a sclerostin-independent pathway. J Bone Miner Res. 2014; 29(11):2456-67. PMC: 4501925. DOI: 10.1002/jbmr.2278. View